AI Analysis AI Analysis of TAK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TAK to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Takeda Pharmaceutical Company Limited stock price down 0.93% on Friday
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 30, 2026 Loss -0.93%

The Takeda Pharmaceutical Company Limited stock price fell by -0.93% on the last day (Friday, 31st Jul 2026) from $17.25 to $17.09. During the last trading day the stock fluctuated 1.45% from a day low at $16.96 to a day high of $17.20. The price has been going up and down for this period, and there has been a -0.35% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 4 million shares were bought and sold for approximately $70.21 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.08% during the next 3 months and, with a 90% probability hold a price between $16.39 and $18.68 at the end of this 3-month period.

TAK Signals & Forecast

The Takeda Pharmaceutical Company Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $17.30. On a fall, the stock will find some support from the long-term average at approximately $16.48. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 29, 2026, and so far it has fallen -3.72%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Takeda Pharmaceutical Company Limited stock

Takeda Pharmaceutical Company Limited finds support from accumulated volume at $16.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.245 (1.45%) between high and low. For the last week, the stock has had daily average volatility of 1.50%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TAK) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Takeda Pharmaceutical Company Limited to open at $17.08, and during the day (based on 14 day Average True Range), to move between $16.92 and $17.26, which gives a possible trading interval of +/-$0.334 (+/-1.97%) up or down from last closing price. If Takeda Pharmaceutical Company Limited takes out the full calculated possible swing range there will be an estimated 1.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $17.23 (0.82%) than the support at $16.73 (2.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Takeda Pharmaceutical Company Limited stock A Buy?

Takeda Pharmaceutical Company Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.461 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $17.08 ( 0.0488%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TAK Performance

Trading levels for TAK

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 17.33 1.38%
R2 17.23 0.84%
R1 17.18 0.499%
Price 17.09
S1 16.99 -0.596%
S2 16.93 -0.93%
S3 16.84 -1.48%

Accumulated Volume Support & Resistance Levels

Level Price
R3 17.75 3.86%
R2 17.25 0.94%
R1 17.23 0.82%
Price 17.09
S1 16.73 -2.11%
S2 16.64 -2.63%
S3 15.72 -8.02%

TAK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 31, 2026 Mar 31, 2026 Mar 31, 2026 $0.298 1.61%
2 Sep 30, 2025 Sep 30, 2025 Sep 30, 2025 $0.321 2.20%
3 Mar 31, 2025 Mar 31, 2025 Mar 31, 2025 $0.319 2.15%
4 Sep 30, 2024 Sep 30, 2024 Sep 30, 2024 $0.333 2.34%
5 Mar 27, 2024 Mar 27, 2024 Mar 27, 2024 $0.301 2.12%

FAQ

What is the symbol for Takeda Pharmaceutical Company Limited Stock and on which exchange is it traded?
The symbol for Takeda Pharmaceutical Company Limited is TAK and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Takeda Pharmaceutical Company Limited Stock?
Takeda Pharmaceutical Company Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Takeda Pharmaceutical Company Limited Stock?
Takeda Pharmaceutical Company Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Takeda Pharmaceutical Company Limited Stock.

What's the current price of Takeda Pharmaceutical Company Limited Stock?
As of the end of day on the Jul 31, 2026, the price of an Takeda Pharmaceutical Company Limited (TAK) share was $17.09.

What is the 52-week high and low for Takeda Pharmaceutical Company Limited Stock?
The 52-week high for Takeda Pharmaceutical Company Limited Stock is $18.90 and the 52-week low is $12.99.

What is the market capitalization of Takeda Pharmaceutical Company Limited Stock?
As of the Jul 31, 2026, the market capitalization of Takeda Pharmaceutical Company Limited is 54.369B.

When is the next earnings date for Takeda Pharmaceutical Company Limited?
The upcoming earnings date for Takeda Pharmaceutical Company Limited is Oct 29, 2026.
Click to get the best stock tips daily for free!
ABOUT TAKEDA PHARMACEUTICAL COMPANY LIMITED
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Reves...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE